ERCC1 polymorphisms in patients with advanced bladder cancer treated with platinum-based chemotherapy

被引：0
|
作者：
Bamias, A.
Nikitas, N.
Karadimou, A.
Gika, D.
Karavasilis, V.
Briasoulis, E. C.
Chrisofos, M.
Murray, S.
Pectasides, D. G.
Dimopoulos, M. A.
机构：
[1] Alexandra Peripheral Gen Hosp, Athens, Greece
[2] Univ Athens, Athens, Greece
[3] Univ Thessaloniki, GR-54006 Thessaloniki, Greece
[4] Hellen Cooperat Oncol Grp Data Off, Athens, Greece
[5] Metropolitan Hosp, Athens, Greece
[6] Univ Athens, Sch Med, Dept Therapeut, GR-11527 Athens, Greece
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e15066
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15066
引用
收藏
页数：1
相关论文
共 50 条
  • [41] An Analysis of HER-2/neu, ERCC1, and GST-pi in Advanced Non-Small Cell Lung Cancer Patients Who are Treated with Platinum-based Chemotherapy
    Seo, Kyung Jin
    Shim, Byoung Yong
    Kim, Hoon Kyo
    Jung, Ji Han
    Yoo, Jinyoung
    Kang, Seok Jin
    Lee, Kyo Young
    KOREAN JOURNAL OF PATHOLOGY, 2008, 42 (06) : 327 - 334
  • [42] Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh
    Bushra, Most Umme
    Rivu, Sanzana Fareen
    Sifat, Ali Ehsan
    Nahid, Noor Ahmed
    Ahmed, Maizbha Uddin
    Al-Mamun, Mir Md Abdullah
    Apu, Mohd Nazmul Hasan
    Islam, Md Siddiqul
    Islam, Md Reazul
    Islam, Mohammad Safiqul
    Hasnat, Abul
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (09) : 7073 - 7082
  • [43] Genetic polymorphisms of GSTP1, XRCC1, XPC and ERCC1: prediction of clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer patients of Bangladesh
    Most. Umme Bushra
    Sanzana Fareen Rivu
    Ali Ehsan Sifat
    Noor Ahmed Nahid
    Maizbha Uddin Ahmed
    Mir Md. Abdullah Al-Mamun
    Mohd Nazmul Hasan Apu
    Md. Siddiqul Islam
    Md. Reazul Islam
    Mohammad Safiqul Islam
    Abul Hasnat
    Molecular Biology Reports, 2020, 47 : 7073 - 7082
  • [44] Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients
    Yu, Dianke
    Shi, Juan
    Sun, Tong
    Du, Xiaoli
    Liu, Li
    Zhang, Xiaojiao
    Lu, Chao
    Tang, Xiaohu
    Li, Meng
    Xiao, Lingchen
    Zhang, Zhouwei
    Yuan, Qipeng
    Yang, Ming
    TUMOR BIOLOGY, 2012, 33 (03) : 877 - 884
  • [45] Prognostic impact of Schlafen 11 in bladder cancer patients treated with platinum-based chemotherapy
    Taniyama, Daiki
    Sakamoto, Naoya
    Takashima, Tsuyoshi
    Takeda, Masahiko
    Quoc Thang Pham
    Ukai, Shoichi
    Maruyama, Ryota
    Harada, Kenji
    Babasaki, Takashi
    Sekino, Yohei
    Hayashi, Tetsutaro
    Sentani, Kazuhiro
    Pommier, Yves
    Murai, Junko
    Yasui, Wataru
    CANCER SCIENCE, 2022, 113 (02) : 784 - 795
  • [46] Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
    Lu, Zheng-mao
    Luo, Tian-hang
    Nie, Ming-ming
    Fang, Guo-en
    Ma, Li-ye
    Xue, Xu-chao
    Wei, Guo
    Ke, Chong-we
    Bi, Jian-wei
    TUMOR BIOLOGY, 2014, 35 (04) : 2941 - 2948
  • [47] Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy
    Yamashita, Fumie
    Azuma, Koichi
    Yoshida, Tsukasa
    Yamada, Kazuhiko
    Kawahara, Akihiko
    Hattori, Satoshi
    Takeoka, Hiroaki
    Zaizen, Yoshiaki
    Kawayama, Tomotaka
    Kage, Masayoshi
    Hoshino, Tomoaki
    PLOS ONE, 2013, 8 (08):
  • [48] Decreased ERCC1 Expression After Platinum-Based Neoadjuvant Chemotherapy in non-Small Cell Lung Cancer
    Podmaniczky, Eszter
    Fabian, Katalin
    Papay, Judit
    Puskas, Rita
    Gyulai, Marton
    Furak, Jozsef
    Tiszlavicz, Laszlo
    Losonczy, Gyoergy
    Timar, Jozsef
    Moldvay, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 423 - 431
  • [49] ERCC1_202 Is A Prognostic Biomarker in Advanced Stage Non-Small Cell Lung Cancer Patients Treated with Platinum-Based Chemotherapy
    Wang, Xiyong
    Zhu, Xiaoli
    Zhang, Hongming
    Fan, Xiaobo
    Xue, Xiulei
    Chen, Yan
    Ding, Chenbo
    Zhao, Jianwen
    Wu, Guoqiu
    JOURNAL OF CANCER, 2017, 8 (14): : 2846 - 2853
  • [50] Expression of ERCC1, MSH2 and PARP1 in Non-small Cell Lung Cancer and Prognostic Value in Patients Treated with Platinum-based Chemotherapy
    Xie, Ke-Jie
    He, Hong-Er
    Sun, Ai-Jing
    Liu, Xi-Bo
    Sun, Li-Ping
    Dong, Xue-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) : 2591 - 2596
12345